NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.
In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.
HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize.
Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.
In Brief: ASCO awards career development grants.
Funding Opportunities listed.
Trending Stories
- Backlog of work grows at NIH as staff members are being hounded to quit
- In the Headlines: What are Jay Bhattacharya’s plans for NIH?
- Rathmell: My mentor recognized a cliff I was going to fall off before I did.
“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.” - The Directors: Ray DuBois and Roy Jensen on how COE guides cancer care in rural America
“We’re just going to have to ride through this and not give up.” - In support of three coordinated CCSG components reducing our national burden of cancer
- In the Headlines: Could “flooding the zone” drown NIH and cancer centers?